AGS MedTech Overview

  • Founded
  • 2010

Founded
  • Status
  • IPO Registration

  • Employees
  • 540

Employees
  • Latest Deal Type
  • IPO

  • (Announced)
  • Investors
  • 3

AGS MedTech General Information

Description

Developer of endoscopic retrograde cholangiopancreatography (ERCP) and gastroenterology devices. The company's medical devices include CO2 Regulation Unit, Water Regulation Unit, ERCP and gastroenterology diagnosis and treatment devices that are used in endoscopy surgeries, enabling medical facilities to provide better treatment and surgery for patients with endoscopic illnesses.

Contact Information

Website
www.bioags.com
Ownership Status
In IPO Registration
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Other Industries
Surgical Devices
Diagnostic Equipment
Primary Office
  • Building 6, No. 597 Kangxin Road
  • Linping District
  • Hangzhou, Zhejiang
  • China
+86 0571 0000 0000

AGS MedTech Timeline

2019202020212022
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

AGS MedTech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. IPO 21-Jun-2022 Announced Profitable
3. IPO 08-Sep-2021 Cancelled Profitable
2. Secondary Transaction - Private 20-Nov-2018 $8.09M Completed Profitable
1. Secondary Transaction - Private 02-Nov-2018 $5.2M Completed Profitable
To view AGS MedTech’s complete valuation and funding history, request access »

AGS MedTech Executive Team (1)

Name Title Board Seat Contact Info
Cheng Zhang Chairman & General Manager
To view AGS MedTech’s complete executive team members history, request access »

AGS MedTech Board Members (1)

Name Representing Role Since
Cheng Zhang AGS MedTech Chairman & General Manager 000 0000
To view AGS MedTech’s complete board members history, request access »

AGS MedTech Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

AGS MedTech Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Daoyuan Capital Venture Capital Minority 000 0000 000000 0
YuanBio Venture Capital Venture Capital Minority 000 0000 000000 0
Zhejiang Silicon Paradise Asset Management Group Growth/Expansion Minority 000 0000 000000 0
To view AGS MedTech’s complete investors history, request access »